The effectiveness of the use of the drug based on silver proteinate in acute and exacerbation of chronic rhinosinusitis

Abstract

Introduction. The presence of opportunistic pathogens within the nasal cavity is one of the important factors in the pathogenesis of acute rhinosinusitis and exacerbation of chronic rhinosinusitis. On top of that, the frequently prescribed ill-founded and uncontrolled use of antibiotics leads to the development of immunoresistance, which contributes to the lack of effectiveness of conservative treatments. This article discusses the therapeutic option for patients with acute rhinosinusitis and exacerbation of chronic rhinosinusitis in the form of a silver proteinate drug in the complex treatment.

Aim. To evaluate the effectiveness of the silver proteinate drug in the complex treatment of acute rhinosinusitis and exacerbation of chronic rhinosinusitis.

Materials and methods. A total of 60 adult patients of both sexes aged 20 to 50 years were included in the study. The first study group (a treatment group) included 30 patients (15 with acute rhinosinusitis and 15 with exacerbation of chronic rhinosinusitis). The second group (a comparison group) also included 30 patients (15 with acute rhinosinusitis and 15 with exacerbation of chronic rhinosinusitis). The treatment group received the silver proteinate drug + decongestants + irrigation therapy + topical corticosteroid therapy as part of the complex treatment. The comparison group received standard therapy: irrigation therapy (solutions to rinse nasal cavities) + decongestants + topical corticosteroid drugs.

Results. Comparative analysis of re-assessment scores for the patients’ status against the timing of use of the silver proteinate drug (Sialor®, tablets for solution for topical use, 200 mg) in the complex treatment showed pronounced improvement in the form of rapid relief of symptoms of the disease and recovery in patients with acute rhinosinusitis and exacerbation of chronic rhinosinusitis in both study groups.

Conclusion. This brings us to the conclusion about the effectiveness and safety of the silver proteinate drug Sialor® in the complex treatment of patients with acute rhinosinusitis and exacerbation of chronic rhinosinusitis, which allows us to recommend it for widespread use in otorhinolaryngological practice.

1. Kryukov AI, Tsarapkin GYu, Tovmasyan AS, Gorovaya EV, Vershinina EA. Administration of topical antimicrobial agents in the complex treatment of upper respiratory tract pathology. RMJ. 2020;(5):32–42. (In Russ.) Available at: https://www.rmj.ru/articles/otorinolaringologiya/Primenenie_mestnyh_antimikrobnyh_sredstv_v_kompleksnom_lechenii_patologii_verhnih_dyhatelynyh_putey.

2. Budkovaya MA, Artemyeva ES. The specific features of nasal breathing disorders in patients with nasal obstruction. Rossiiskaya Otorinolaringo­ logiya. 2019;18(1):16–23. (In Russ.) https://doi.org/10.18692/1810-4800-2019-1-16-23.

3. Shilenkova VV, Fedoseeva OV. Nasal cycle and rhinosinusitis: a new look at the problem. Rossiiskaya Otorinolaringologiya. 2019;18(2):70–76. (In Russ.) https://doi.org/10.18692/1810-4800-2019-2-70-76.

4. Zolotareva MA, Nazaruk EI. Orbital and intracranial complications of inflammatory diseases of paranasal sinuses in adults based on case studies of Department of Otorhinolaryngology of N. A. Semashko Republican Clinical Hospital for the period 2014 to 2018. Rossiiskaya Otorinolaringologiya. 2020;19(1):37–45. (In Russ.) https://doi.org/10.18692/1810-4800-2020-1-37-45.

5. Krivopalov AA, Moroz NV, Artyushkin SA, Shamkina PA, Zakharova GP. Assessment of prevalence of chronic rhinosinusitis. Rossiiskaya Otorinolaringologiya. 2022;21(5):91–98. (In Russ.) https://doi.org/10.18692/1810-4800-2022-5-91-98.

6. Karpishchenko SA, Fatalieva AF. Modern concept of acute rhinosinusitis treatment. RMJ. Medical Review. 2019;9(II):93–96. (In Russ.) Available at: https://www.rmj.ru/articles/otorinolaringologiya/Sovremennaya_koncepciya_lecheniya_ostrogo_rinosinusita.

7. Nakatis YaA, Rymsha MA. Prevention and treatment of rhinitis – prevention of sinusitis and otitis media in children. Folia Otorhinolaryngologiae et Pathologiae Respiratoriae. 2015;21(3):70–71. (In Russ.) Available at: https://drive.google.com/file/d/135-zIk6PKgmPVj3x3LUpndBfYLlV-hVP/view.

8. Karpishchenko SA, Bolozneva EV, Mushnikova YuV. Active anterior rhinomanometry, as an approach for measuring the efficiency of treatment of patients with rhinological pathology. Folia Otorhinolaryngologiae et Pathologiae Respiratoriae. 2016;22(2):20–25 (In Russ.) Available at: https://drive.google.com/file/d/1ilSJY4zDJWN_U8HYpq4rCBiKAK6ug9xz/view.

9. Svistushkin VM, Shevchik EA. Acute rhinosinusitis is a modern view of the problem. RMJ. 2014;(9):643–646. (In Russ.) Available at: https://www.rmj.ru/data/articles/Image/t22/n9/RMJ_22_9_2014.pdf.

10. Волчкова ЕВ, Герасимов СГ, Ордова СН, Слепцова СС, Кравченко ИЭ, Фазылов ВХ. Острые респираторные инфекции у взрослых: клинические рекомендации. 2014. 69 с. Режим доступа: https://oblzdrav.volgograd.ru/docs/My%20Folder/ORVI_u_vzroslykh.pdf?ysclid=lmq3lsglxm31250048.

11. Brook I. Effects of exposure to smoking on the microbial flora of children and their parents. Int J Pediatr Otorhinolaryngol. 2010;74(5):447–450. https://doi.org/10.1016/j.ijporl.2010.01.006.

12. Lopatin AS, Ovchinnikov AYu, Svistushkin VM, Nikiforova GN. Topical drugs for the treatment of acute and chronic rhinitis. Consilium Medicum. 2003;5(4):219–222. (In Russ.) Available at: https://consilium.orscience.ru/2075-1753/article/view/91611.

13. Garashchenko TI, Tarasova GD, Yunusov AS, Tulina AS, Garashchenko MV. Postviral rhinosinusitis in children: the possibilities of topical monotherapy. Rossiiskaya Otorinolaringologiya. 2020;19(1):110–117. (In Russ.) https://doi.org/10.18692/1810-4800-2020-1-110-117.

14. Ryazantsev SV, Pavlova SS. Difficult nasal breathing in the ENT-practice: how to help? Rossiiskaya Otorinolaringologiya. 2020;19(2):107–115. (In Russ.) https://doi.org/10.18692/1810-4800-2020-2-107-115.

15. Gurov AV, Yushkina MA. The opportunities of local therapy of pyoinflammatory diseases of the nasal cavity. RMJ. 2017;(6):410–413. (In Russ.) Available at: https://www.rmj.ru/articles/otorinolaringologiya/Vozmoghnosti_mestnoy_terapii_gnoyno-vospalitelynyh_zabolevaniy_polosti_nosa.

16. Alekseenko SI, Dvoryanchikov VV, Artyushkin SA, Barashkova SV, Anikin IA, Isachenko VS. Relationship between disorders of ciliary apparatus of epithelium of nasal mucosa and severity of sinonasal pathology in children with chronic rhinosinusitis. Rossiiskaya Otorinolaringologiya. 2022;21(1):8–18. (In Russ.) https://doi.org/10.18692/1810-4800-2022-1-8-18.

17. Lavrenova GV, Gas’kova PI, Oganyan KA. Irrigation therapy as basic method for preventing aging of nasal mucosa. Rossiiskaya Otorinolaringologiya. 2022;21(4):135–140. (In Russ.) https://doi.org/10.18692/1810-4800-2022-4-135-140.

18. Bodzhokov AA, Polyakov DP, Degtyareva DV. Modern methods of treatment of chronic rhinosinusitis in children. Rossiiskaya Otorinolaringologiya. 2023;22(1):74–78. (In Russ.) https://doi.org/10.18692/1810-4800-2023-1-74-78.

19. Danilova EI, Trusova OYu. Effectiveness of combined therapy of acute rhinosinusitis in children. Meditsinskiy Sovet. 2018;(17):84–89. (In Russ.) https://doi.org/10.21518/2079-701X-2018-17-118-123.

20. Brochado AR, Telzerow A, Bobonis J. Species-specific activity of antibacterial drug combinations. Nature. 2018;559(7713):259–263. https://doi.org/10.1038/s41586-018-0278-9.

21. Principi N, Esposito S. New insights into pediatric rhinosinusitis. Pediatr Allergy Immunol. 2007;18(Suppl. 18):7–9. https://doi.org/10.1111/j.1399-3038.2007.00623.x.

22. Morones-Ramirez JR, Winkler JA, Spina CS, Collins JJ. Silver enhances antibiotic activity against gram-negative bacteria. Sci Transl Med. 2013;5:1–11. https://doi.org/10.1126/scitranslmed.3006276.

23. Kim J, Pitts B, Stewart PS, Camper A, Yoon J. Comparison of the antimicrobial effects of chlorine, silver ion, and tobramycin on biofilm. Antimicrob Agents Chemother. 2008;52:1446–1453. https://doi.org/10.1128/AAC.00054-07.

24. Костылева РН, Бурмистров ВА. Сравнительное изучение бактерицидной активности препаратов коллоидного серебра. В: Серебро и висмут в медицине: материалы научно­практической конференции с междуна­ родным участием. Новосибирск, 25–26 февраля 2005 г. Новосибирск: Сиб. ун-т потреб. кооп.; 2005. 310 с. Режим доступа: http://vector-vita.narod.ru/Documents/2005/SerebroVismut2005_09.pdf.

25. Savvateeva DM. The place of antiseptic drugs in the treatment of patients with acute infectious diseases of the upper respiratory tract. RMJ. 2015;(6):336–338 (In Russ.) Available at: https://www.rmj.ru/articles/otorinolaringologiya/Mesto_antisepticheskih_preparatov_v_lechenii_pacientov_s_ostrymi_infekcionnymi_zabolevaniyami_verhnih_dyhatelynyh_putey.

26. Babenko GA. On the use of the silver microelement in medicine. Trace Elements in Medicine. 1977;(7):3–8. (In Russ.)

27. Eremeeva KV, Petrova EI, Svistushkin VM. Silver proteinate in ENT practice: is the new a well-forgotten old? RMJ. 2015;(23):1381–1383. (In Russ.) Available at: https://www.rmj.ru/articles/otorinolaringologiya/Proteinat_ serebra_v_LOR-praktike_novoe eto_horoshozabytoe_staroe.

28. Khrustaleva EV, Pedder VV. Possibilities of using silver proteinate in the treatment of rhinosinusitis. RMJ. Medical Review. 2019;2(2):54–58. (In Russ.) Available at: https://www.rusmedreview.com/articles/otorinolaringologiya/Vozmoghnosti_primeneniya_proteinata_serebra_v_kompleksnoy_terapii_rinosinusitov.